Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Thursday, January 7, 2010, 1:58PM ET - U.S. Markets close in 2 hours and 2 minutes. Dow Up 0.07% Nasdaq Down 0.38%
OSI Pharmaceuticals Inc. (OSIP)At 1:43PM ET: 32.00  Up 0.09 (0.28%)  
MORE ON OSIP
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Wed, Jan 6, 2010
OSI Pharmaceuticals to Present at the 28th Annual JP Morgan Healthcare Conference on Tuesday, January 12, 2010
Business Wire (Wed 11:38am)
Mon, Jan 4, 2010
Biotech Calendar: Key Dates for January
at TheStreet.com (Mon, Jan 4)
Thu, Dec 31, 2009
5-Star Stocks on the Upswing
at Motley Fool (Thu, Dec 31)
Wed, Dec 30, 2009
Pfizer Pflubs -- You Expected Otherwise?
at Motley Fool (Wed, Dec 30)
Tue, Dec 29, 2009
UPDATE - Pfizer ends late-stage lung-cancer study
at Reuters (Tue, Dec 29)
U.S. Patent and Trademark Office Grants Reissued Patent Replacing OSI Pharmaceuticals' Tarceva® Composition of Matter Patent
Business Wire (Tue, Dec 29)
Mon, Dec 28, 2009
4-Star Stocks on the Upswing
at Motley Fool (Mon, Dec 28)
Wed, Dec 23, 2009
OSIP Narrows 2010 Revenue Guidance
Zacks.com (Wed, Dec 23)
Tue, Dec 22, 2009
OSI Pharmaceuticals trims 2010 revenue outlook
AP (Tue, Dec 22)
OSI Pharmaceuticals Updates Preliminary Revenue & Re-affirms Adjusted Earnings Growth Rate Guidance for 2010
Business Wire (Tue, Dec 22)
Fri, Dec 18, 2009
Setback for OSIP's Tarceva
Zacks.com (Fri, Dec 18)
Thu, Dec 17, 2009
Biotech Stocks: Drug stocks chase broader market south
at MarketWatch (Thu, Dec 17)
Lilly to Benefit from OSI Rejection
at Seeking Alpha (Thu, Dec 17)
Aveo Pharma registers for potential IPO
at bizjournals.com (Thu, Dec 17)
Biotech Stocks: Drug stocks slip; OSI slides on FDA move
at MarketWatch (Thu, Dec 17)
Wed, Dec 16, 2009
Panel Rejects Early Use of Tarceva
at The Wall Street Journal Online (Wed, Dec 16)
UPDATE - US FDA panel rejects early use of Tarceva
at Reuters (Wed, Dec 16)
FDA panel votes down new use for OSI cancer drug
AP (Wed, Dec 16)
OSI Pharmaceuticals Announces Conference Call on ODAC Review of Tarceva® for Use as First-line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Business Wire (Wed, Dec 16)
FDA Advisory Committee Recommends Against Approving Tarceva for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Business Wire (Wed, Dec 16)
Older Headlines - Download Recent Headlines
View headlines from:
Add OSIP News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage